Express delivery and free returns within 21 days

Tuesday, July 5, 2022

MEDICAL DEVICE NEWS MAGAZINE

|

Contact us 561.316.3330

ProCure Proton Therapy Center Offers Non-Invasive Solution

ProCure Proton Therapy Center reports that Tom Corlett, a retired New Jersey resident, first learned of his brain tumor by accident, when sinus pain drove him to see his doctor. Several tests later, he was shocked to discover that it was not sinus pain but instead a golf-ball-sized meningioma brain tumor sitting right behind his nose.

As the tumor continued growing, Corlett braced himself for surgery, which he thought was the only viable option, although he was terrified of taking this invasive route.

But after more research, Corlett learned about a non-invasive option at ProCure Proton Therapy Center. Proton therapy is a highly advanced form of radiation treatment that, unlike standard radiation, safely and precisely destroys cancer cells while sparing surrounding healthy tissue.

In Corlett’s case, he chose ProCure because it effectively stopped the tumor from growing. “I had no residual effects from the procedure,” Corlett said. “Physically, I feel fine. I’m back to playing golf and chasing the grandkids around.”

Dr. Brian Chon, ProCure Proton Therapy Center Medical Director, said proton therapy’s precision makes it ideal for many types of cancers, including complex cases and recurrent tumors. Proton therapy can help preserve neurocognitive function by limiting doses to the normal, uninvolved brain when compared to X-ray based treatments.

“We are grateful to play a role in Tom’s journey,” Dr. Chon said. “Brain tumors can significantly impact quality of life, and they are sometimes near critical organs. This often makes proton therapy a good option.”

Subscribe to Medical Device News Magazine
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

PhysioMedics Poised for Growth Through Capital Fundraise Following CEO Appointment

Edinburgh-based PhysioMedics secured equity and grant funding totalling £1.5m from Archangels, Scottish Enterprise and Innovate UK.

Advanced NanoTherapies Announces Closing of Oversubscribed $7.2 Million Series A Financing

Funds will be used to complete the first-in-human clinical study in Australia of the SirPlux Duo drug-coated balloon in de-novo coronary artery disease lesions notes Advanced NanoTherapies.

Centerline Biomedical Raises $33 Million in Series B Financing

Centerline Biomedical notes their flagship product, IOPS® (Intra-Operative Positioning System) was developed in Cleveland Clinic's Heart and Vascular Institute and utilizes patented algorithms to generate a patient-specific vascular map combined with electromagnetic tracking and smart sensor-equipped surgical devices to provide real-time, 3-D color visualization and navigation of the human vascular system.

By using this website you agree to accept Medical Device News Magazine Privacy Policy